| Trial ID: | L0099 |
| Source ID: | NCT01071993
|
| Associated Drug: |
Placebo
|
| Title: |
Efficacy of Statins In Prevention of CIN
|
| Acronym: |
SCIN
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01071993/results
|
| Conditions: |
Nephropathy
|
| Interventions: |
DRUG: placebo|DRUG: atorvastatin
|
| Outcome Measures: |
Primary: Primary Endpoint. Development of CIN (Contrast-induced Nephropathy) Defined as a Postprocedure Increase in Serum Creatinine of > 0.5 mg/dL or >25% Increase From Baseline at 24 & at 48 Hours., Development of CIN (Contrast-induced Nephropathy) Defined as a Postprocedure Increase in Serum Creatinine of \> 0.5 mg/dL or \>25% Increase From Baseline at 24 \& at 48 Hours, 48 hours |
|
| Sponsor/Collaborators: |
Sponsor: University of Oklahoma
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
21
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2010-03
|
| Completion Date: |
2013-07
|
| Results First Posted: |
2017-09-13
|
| Last Update Posted: |
2017-12-04
|
| Locations: |
Oklahoma University Health Science Center, Oklahoma City, Oklahoma, 73104, United States|Veterans Affairs Medical Center, Oklahoma City, Oklahoma, 73104, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01071993
|
